Cargando…
Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease
Paricalcitol, a selective vitamin D receptor (VDR) activator used for treatment of secondary hyperparathyroidism in chronic kidney disease (CKD), has been associated with survival advantages, suggesting that this drug, beyond its ability to suppress parathyroid hormone, may have additional beneficia...
Autores principales: | Donate-Correa, J., Domínguez-Pimentel, V., Méndez-Pérez, M. L., Muros-de-Fuentes, M., Mora-Fernández, C., Martín-Núñez, E., Cazaña-Pérez, V., Navarro-González, J. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913352/ https://www.ncbi.nlm.nih.gov/pubmed/24511210 http://dx.doi.org/10.1155/2014/670475 |
Ejemplares similares
-
Inflammatory Cytokines in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2015) -
Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease
por: Donate‐Correa, Javier, et al.
Publicado: (2015) -
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021) -
Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2021) -
Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients
por: Pérez-Morales, Rosa, et al.
Publicado: (2021)